About United Therapeutics
United Therapeutics (NASDAQ:UTHR) is a biotechnology company focused on developing and commercializing innovative products to address the unmet medical needs of patients with chronic and life-threatening diseases. With a keen interest in pulmonary arterial hypertension (PAH) and other similar conditions, United Therapeutics is dedicated to pushing the boundaries of science to improve patient outcomes. Their operations span from research and development to the commercialization of unique therapies. Key projects include advancing treatments in lung transplantation and pulmonary diseases, with the objective of expanding therapeutic options and enhancing quality of life for patients. Through their commitment to innovation and patient care, United Therapeutics aims to lead the way in biotechnological advancements and health solutions.
Snapshot
Operations
Products and/or services of United Therapeutics
- Remodulin (treprostinil) Injection, used to treat pulmonary arterial hypertension (PAH), improves exercise ability and delays disease progression.
- Tyvaso (treprostinil) Inhalation Solution, for PAH and pulmonary hypertension associated with interstitial lung disease, enhances exercise capacity.
- Adcirca (tadalafil), an oral medication for PAH, helps increase exercise ability.
- Unituxin (dinutuximab), an immunotherapy for pediatric high-risk neuroblastoma, improves survival rates.
- Orenitram (treprostinil) Extended-Release Tablets, for PAH, aids in improving exercise capacity and delaying clinical worsening.
- Implantable System for Remodulin (ISR), a delivery system for Remodulin, enhances patient convenience and treatment adherence for PAH.
United Therapeutics executive team
- Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.Founder, Chairman & CEO
- Mr. Michael I. BenkowitzPresident & COO
- Mr. James C. EdgemondCFO & Treasurer
- Mr. Paul A. Mahon J.D.Executive VP, General Counsel & Corporate Secretary
- Harrison SilversManager of Investor Relations
- Ms. Holly HobsonAssociate Vice President of Human Resources
- Kevin T. GraySenior Vice President of Strategic Operations & Logistics
- Mr. Patrick PoissonExecutive VP of Technical Operations
- Dr. Leigh PetersonExecutive Vice President of Product Development & Xenotransplantation
- Mr. Gil GoldenSenior VP & Chief Medical Officer